U.S.
New drug combo shrinks tumors in most patients facing aggressive cancer type
CRAYON summary
Fox News reports that a daily pill called daraxonrasib, given alongside chemotherapy in a pancreatic cancer trial, shrank tumors in 60.7% of patients and halted tumor growth in 90.2%, according to researchers. The outlet adds that 8.2% of patients saw their tumors disappear on scans.
Based on Fox News's report - only one outlet has covered this so far. Read the original.▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological.
-
New drug combo shrinks tumors in most patients facing aggressive cancer type
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.
Discussion 0 comments